Market Closed -
OTC Markets
20:14:47 29/12/2023 GMT
|
5-day change
|
1st Jan Change
|
37.45
USD
|
+27.29%
|
|
-.--%
|
-.--%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
185,022,773
|
161,839,196
|
158,424,267
|
222,334,671
|
454,185,612
|
798,069,003
|
-
|
-
|
Enterprise Value (EV)
2 |
186,976
|
160,773
|
144,795
|
223,252
|
458,956
|
801,829
|
801,662
|
793,409
|
P/E ratio
|
534
x
|
219
x
|
68.2
x
|
-
|
-662
x
|
1,343
x
|
656
x
|
-
|
Yield
|
0.05%
|
-
|
0.81%
|
-
|
-
|
-
|
0.35%
|
1.05%
|
Capitalization / Revenue
|
6.58
x
|
6.27
x
|
4.29
x
|
6.23
x
|
13.3
x
|
21.5
x
|
20.8
x
|
22.4
x
|
EV / Revenue
|
6.65
x
|
6.23
x
|
3.92
x
|
6.26
x
|
13.4
x
|
21.6
x
|
20.9
x
|
22.2
x
|
EV / EBITDA
|
70.2
x
|
61.5
x
|
28.7
x
|
-797
x
|
341
x
|
284
x
|
136
x
|
122
x
|
EV / FCF
|
-144
x
|
40.2
x
|
-
|
-
|
807
x
|
828
x
|
-191
x
|
-
|
FCF Yield
|
-0.69%
|
2.49%
|
-
|
-
|
0.12%
|
0.12%
|
-0.52%
|
-
|
Price to Book
|
6.89
x
|
62.7
x
|
3.78
x
|
4.36
x
|
8.12
x
|
17.8
x
|
18.7
x
|
17.8
x
|
Nbr of stocks (in thousands)
|
71,334,081
|
71,334,081
|
86,511,545
|
86,511,545
|
86,511,545
|
86,511,545
|
-
|
-
|
Reference price
3 |
2,594
|
2,269
|
1,831
|
2,570
|
5,250
|
9,225
|
9,225
|
9,225
|
Announcement Date
|
16/03/20
|
03/03/21
|
15/03/22
|
31/03/23
|
29/03/24
|
-
|
-
|
-
|
1IDR in Million2IDR in Billions3IDR Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
28,104
|
25,798
|
36,944
|
35,671
|
34,241
|
37,199
|
38,409
|
35,693
|
EBITDA
1 |
2,664
|
2,614
|
5,053
|
-280
|
1,344
|
2,827
|
5,897
|
6,520
|
EBIT
1 |
1,293
|
1,163
|
3,632
|
-1,739
|
-441.9
|
1,101
|
4,199
|
4,795
|
Operating Margin
|
4.6%
|
4.51%
|
9.83%
|
-4.87%
|
-1.29%
|
2.96%
|
10.93%
|
13.43%
|
Earnings before Tax (EBT)
|
579.3
|
411.8
|
2,895
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
341.9
|
733.4
|
2,178
|
-
|
-532.3
|
599.3
|
1,215
|
-
|
Net margin
|
1.22%
|
2.84%
|
5.9%
|
-
|
-1.55%
|
1.61%
|
3.16%
|
-
|
EPS
2 |
4.856
|
10.35
|
26.84
|
-
|
-7.926
|
6.870
|
14.05
|
-
|
Free Cash Flow
3 |
-1,296,795
|
3,996,424
|
-
|
-
|
568,647
|
968,006
|
-4,199,897
|
-
|
FCF margin
|
-4,614.3%
|
15,491.32%
|
-
|
-
|
1,660.7%
|
2,602.24%
|
-10,934.64%
|
-
|
FCF Conversion (EBITDA)
|
-
|
152,871.51%
|
-
|
-
|
42,297.53%
|
34,245%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
544,948.59%
|
-
|
-
|
-
|
161,536.2%
|
-
|
-
|
Dividend per Share
2 |
1.382
|
-
|
14.89
|
-
|
-
|
-
|
32.35
|
97.06
|
Announcement Date
|
16/03/20
|
03/03/21
|
15/03/22
|
31/03/23
|
29/03/24
|
-
|
-
|
-
|
1IDR in Billions2IDR3IDR in Million Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
1,953
|
-
|
-
|
917
|
4,770
|
3,760
|
3,593
|
-
|
Net Cash position
1 |
-
|
1,066
|
13,629
|
-
|
-
|
-
|
-
|
4,660
|
Leverage (Debt/EBITDA)
|
0.7331
x
|
-
|
-
|
-3.277
x
|
3.548
x
|
1.33
x
|
0.6092
x
|
-
|
Free Cash Flow
2 |
-1,296,795
|
3,996,424
|
-
|
-
|
568,647
|
968,006
|
-4,199,897
|
-
|
ROE (net income / shareholders' equity)
|
1.3%
|
2.88%
|
6.43%
|
-5.22%
|
-1.21%
|
0.37%
|
4.66%
|
6.72%
|
ROA (Net income/ Total Assets)
|
0.69%
|
1.46%
|
3.54%
|
-
|
-0.64%
|
0.8%
|
1.5%
|
-
|
Assets
1 |
49,490
|
50,304
|
61,471
|
-
|
83,574
|
74,906
|
81,030
|
-
|
Book Value Per Share
3 |
376.0
|
36.20
|
484.0
|
589.0
|
647.0
|
518.0
|
493.0
|
518.0
|
Cash Flow per Share
3 |
51.20
|
77.80
|
39.40
|
-52.40
|
31.20
|
21.80
|
52.40
|
53.90
|
Capex
1 |
4,939
|
1,550
|
1,158
|
-
|
1,527
|
2,342
|
8,587
|
-
|
Capex / Sales
|
17.58%
|
6.01%
|
3.14%
|
-
|
4.46%
|
6.3%
|
22.36%
|
-
|
Announcement Date
|
16/03/20
|
03/03/21
|
15/03/22
|
31/03/23
|
29/03/24
|
-
|
-
|
-
|
1IDR in Billions2IDR in Million3IDR Last Close Price
9,225
IDR Average target price
1,840
IDR Spread / Average Target -80.05% Consensus |
1st Jan change
|
Capi.
|
---|
| +2.46% | 99.64B | | -11.38% | 59.01B | | +5.26% | 34.94B | | +0.61% | 31.15B | | +3.47% | 18.62B | | +17.33% | 17.44B | | +5.92% | 13.51B | | -6.67% | 12.73B | | -25.86% | 12.04B |
Other Commodity Chemicals
|